BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q2 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
---|---|---|---|---|---|---|---|---|---|---|
BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 4/17/2024- NAV $48.95
- NAV Change $-0.58
- Market Price $48.95
- Market Price Change $-0.60
- Trading Volume (M) 15,963
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 4/17/2024- NAV $48.95
- NAV Change $-0.58
- Market Price $48.95
- Market Price Change $-0.60
- Trading Volume (M) 15,963
- 30-Day Median Bid Ask Spread 0.21%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 3/28/2024
Holdings
as of 4/17/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
44.02% | -- | NASDAQ BIO INDEX SWAP BNP | 35,013,298 | -- | 8,547 | -- |
37.03% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 29,454,266 | -- | 7,190 | -- |
17.17% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 13,657,931 | -- | 3,334 | -- |
12.48% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 9,930,061 | -- | 2,424 | -- |
6.80% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,411,556 | -- | 1,321 | -- |
6.24% | AMGN | AMGEN INC | -- | $4,960,554.95 | 18,785 | 2023607 |
6.04% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,806,040.60 | 12,226 | 2931034 |
6.03% | REGN | REGENERON PHARMACEUTICALS | -- | $4,799,737.94 | 5,326 | 2730190 |
6.00% | GILD | GILEAD SCIENCES INC | -- | $4,774,986.99 | 71,343 | 2369174 |
5.37% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,268,616 | -- | 1,042 | -- |
3.52% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 2,797,950 | -- | 683 | -- |
3.29% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,620,381.61 | 38,237 | 2989044 |
3.26% | MRNA | MODERNA INC | -- | $2,595,413.04 | 25,091 | BGSXTS3 |
2.31% | BIIB | BIOGEN INC | -- | $1,834,167.20 | 9,545 | 2455965 |
1.55% | ILMN | ILLUMINA INC | -- | $1,234,119.57 | 10,433 | 2613990 |
1.51% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,202,087.04 | 8,272 | B00FWN1 |
1.41% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $1,120,651.89 | 12,387 | 2437071 |
1.09% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $870,924.51 | 6,537 | 2623911 |
1.09% | VTRS | VIATRIS INC | -- | $865,578.00 | 77,980 | BMWS3X9 |
1.04% | SNY | SANOFI-ADR | -- | $829,426.68 | 17,988 | 2964557 |
1.02% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $809,911.74 | 29,334 | BMVP7Y0 |
0.98% | INCY | INCYTE CORP | -- | $777,409.12 | 14,746 | 2471950 |
0.97% | MEDP | MEDPACE HOLDINGS INC | -- | $772,911.24 | 2,021 | BDCBC61 |
0.94% | ARGX | ARGENX SE - ADR | -- | $748,146.60 | 2,043 | BDVLM39 |
0.91% | UTHR | UNITED THERAPEUTICS CORP | -- | $727,578.52 | 3,092 | 2430412 |
0.91% | SRPT | SAREPTA THERAPEUTICS INC | -- | $726,673.96 | 6,164 | B8DPDT7 |
0.69% | ROIV | ROIVANT SCIENCES LTD | -- | $552,443.04 | 52,916 | BMW4NZ9 |
0.69% | BNTX | BIONTECH SE-ADR | -- | $549,158.40 | 6,356 | BK6H543 |
0.67% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $536,407.41 | 3,773 | BV9G6B8 |
0.61% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $487,748.40 | 6,360 | BHCB0P4 |
0.58% | CYTK | CYTOKINETICS INC | -- | $459,274.73 | 6,761 | BBBSBJ5 |
0.57% | EXEL | EXELIXIS INC | -- | $455,364.57 | 19,911 | 2576941 |
0.56% | PCVX | VAXCYTE INC | -- | $444,251.88 | 7,116 | BKPVGH6 |
0.55% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $438,253.20 | 4,092 | B4Q5ZN4 |
0.50% | RVMD | REVOLUTION MEDICINES INC | -- | $398,281.94 | 10,817 | BL71K91 |
0.49% | IONS | IONIS PHARMACEUTICALS INC | -- | $391,672.34 | 9,574 | BDJ0LS6 |
0.48% | APLS | APELLIS PHARMACEUTICALS INC | -- | $380,445.63 | 7,921 | BYTQ6X1 |
0.45% | BGNE | BEIGENE LTD-ADR | -- | $358,527.34 | 2,719 | BYYWPW6 |
0.45% | BPMC | BLUEPRINT MEDICINES CORP | -- | $355,464.36 | 4,022 | BWY52P3 |
0.40% | HALO | HALOZYME THERAPEUTICS INC | -- | $316,554.52 | 8,326 | 2975098 |
0.40% | KRYS | KRYSTAL BIOTECH INC | -- | $314,851.84 | 1,856 | BD6JX35 |
0.38% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $298,668.72 | 1,308 | BD59BS7 |
0.37% | CRSP | CRISPR THERAPEUTICS AG | -- | $292,912.32 | 5,272 | BDHF4K6 |
0.36% | BBIO | BRIDGEBIO PHARMA INC | -- | $288,394.10 | 11,545 | BK1KWG8 |
0.35% | ALPN | ALPINE IMMUNE SCIENCES INC | -- | $277,564.76 | 4,306 | BYX38M1 |
0.34% | IMVT | IMMUNOVANT INC | -- | $271,222.20 | 9,540 | BJRFSB7 |
0.33% | ALKS | ALKERMES PLC | -- | $263,389.70 | 10,970 | B3P6D26 |
0.32% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $255,576.22 | 5,234 | BMX9K07 |
0.32% | INSM | INSMED INC | -- | $255,202.64 | 9,748 | 2614487 |
0.31% | NUVL | NUVALENT INC-A | -- | $247,491.00 | 3,852 | BMVBZD3 |
0.30% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $238,546.88 | 5,408 | BJ62Z18 |
0.29% | IBRX | IMMUNITYBIO INC | -- | $229,737.32 | 43,843 | BNSP0B8 |
0.27% | AXSM | AXSOME THERAPEUTICS INC | -- | $216,728.39 | 3,109 | BYZR4X4 |
0.27% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $216,423.80 | 18,341 | BF0DMK7 |
0.27% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $213,624.73 | 4,843 | BGMGM89 |
0.27% | FTRE | FORTREA HOLDINGS INC | -- | $212,816.79 | 5,829 | BRXYZ57 |
0.26% | XENE | XENON PHARMACEUTICALS INC | -- | $206,193.39 | 4,953 | BRJ3GY4 |
0.26% | FOLD | AMICUS THERAPEUTICS INC | -- | $204,617.25 | 19,395 | B19FQ48 |
0.25% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $201,257.73 | 4,573 | BDD19F8 |
0.25% | IDYA | IDEAYA BIOSCIENCES INC | -- | $196,591.98 | 4,894 | BK0VHF6 |
0.23% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $186,047.37 | 10,823 | 2713317 |
0.23% | ACLX | ARCELLX INC | -- | $185,550.75 | 3,465 | BPCJ1Q2 |
0.23% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $183,349.14 | 8,138 | BYQBFJ8 |
0.21% | SMMT | SUMMIT THERAPEUTICS INC | -- | $164,491.32 | 46,076 | BMTVQS7 |
0.20% | JANX | JANUX THERAPEUTICS INC | -- | $159,514.96 | 3,326 | BMFX8Y7 |
0.20% | MRUS | MERUS NV | -- | $156,072.10 | 3,802 | BZBY005 |
0.19% | DNLI | DENALI THERAPEUTICS INC | -- | $153,684.34 | 9,137 | BD2B4V0 |
0.19% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $151,723.70 | 3,946 | BF2YWG4 |
0.19% | ARVN | ARVINAS INC | -- | $149,588.40 | 4,472 | BDZ30Q0 |
0.18% | VCEL | VERICEL CORP | -- | $146,690.46 | 3,171 | BSBMN89 |
0.18% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $140,753.92 | 5,944 | BDFKQ07 |
0.18% | KROS | KEROS THERAPEUTICS INC | -- | $140,055.01 | 2,363 | BM7V485 |
0.17% | VERA | VERA THERAPEUTICS INC | -- | $137,994.49 | 3,449 | BL55460 |
0.17% | NTLA | INTELLIA THERAPEUTICS INC | -- | $135,729.50 | 6,313 | BYZM6C2 |
0.17% | KYMR | KYMERA THERAPEUTICS INC | -- | $135,478.88 | 4,013 | BMPRZV5 |
0.17% | DYN | DYNE THERAPEUTICS INC | -- | $132,240.96 | 5,328 | BN15WD1 |
0.17% | GERN | GERON CORP | -- | $131,946.40 | 35,855 | 2370381 |
0.16% | GH | GUARDANT HEALTH INC | -- | $131,005.27 | 7,993 | BFXC911 |
0.16% | BEAM | BEAM THERAPEUTICS INC | -- | $130,374.53 | 5,363 | BK6L288 |
0.16% | PTCT | PTC THERAPEUTICS INC | -- | $126,529.64 | 5,029 | B17VCN9 |
0.16% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $126,437.85 | 3,157 | BNFWZS4 |
0.16% | APGE | APOGEE THERAPEUTICS INC | -- | $125,660.00 | 2,440 | BM9HHL5 |
0.16% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $123,514.54 | 2,263 | BLCD809 |
0.16% | RNA | AVIDITY BIOSCIENCES INC | -- | $123,331.35 | 5,237 | BMWHPY1 |
0.15% | SANA | SANA BIOTECHNOLOGY INC | -- | $119,588.28 | 14,478 | BMFJJ97 |
0.15% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $118,475.72 | 3,196 | BQS9486 |
0.15% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $115,729.20 | 5,580 | BN7Q7R7 |
0.14% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $111,429.99 | 14,917 | BM9FJ13 |
0.14% | MYGN | MYRIAD GENETICS INC | -- | $110,031.92 | 5,903 | 2614153 |
0.14% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $108,732.75 | 3,725 | BKSGZN7 |
0.14% | TWST | TWIST BIOSCIENCE CORP | -- | $108,480.29 | 3,797 | BGKG6G7 |
0.14% | INBX | INHIBRX INC | -- | $107,671.71 | 3,111 | BK1MBC3 |
0.13% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $107,062.64 | 3,688 | BCBVTX1 |
0.13% | -- | AVADEL PHARMACEUTICALS PLC ADR USD | -- | $106,015.07 | 5,893 | -- |
0.13% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $104,139.00 | 3,591 | B72ZBG4 |
0.13% | FUSN | FUSION PHARMACEUTICALS INC | -- | $100,932.48 | 4,752 | BJK0NH0 |
0.13% | ARDX | ARDELYX INC | -- | $100,097.10 | 15,282 | BN89V40 |
0.12% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $98,046.54 | 8,578 | BRJZSK0 |
0.12% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $97,805.25 | 3,825 | BDCBCD8 |
0.12% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $95,684.10 | 6,114 | BKY5JZ8 |
0.12% | VCYT | VERACYTE INC | -- | $93,017.52 | 4,932 | BFTWZY0 |
0.12% | LGND | LIGAND PHARMACEUTICALS | -- | $91,725.81 | 1,163 | 2501578 |
0.12% | MORF | MORPHIC HOLDING INC | -- | $91,525.08 | 3,284 | BK8M4J4 |
0.11% | ANIP | ANI PHARMACEUTICALS INC | -- | $90,558.84 | 1,383 | BCDWBX6 |
0.11% | ADMA | ADMA BIOLOGICS INC | -- | $90,509.40 | 14,985 | B9NSBM2 |
0.11% | KURA | KURA ONCOLOGY INC | -- | $89,950.00 | 5,000 | BYZD465 |
0.11% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $85,179.60 | 5,736 | BLB0YH0 |
0.11% | NVCR | NOVOCURE LTD | -- | $84,711.50 | 7,030 | BYSS4X4 |
0.10% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $82,731.00 | 3,270 | BKLXFX5 |
0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $81,809.12 | 3,056 | B3X26D8 |
0.10% | AKRO | AKERO THERAPEUTICS INC | -- | $79,833.60 | 3,696 | BK7Y2V9 |
0.10% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $78,649.65 | 10,281 | B3MZ6K5 |
0.10% | GMAB | GENMAB A/S -SP ADR | -- | $78,514.56 | 2,752 | BBC9WC7 |
0.10% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $78,089.60 | 5,305 | BZ1LFB2 |
0.10% | TARS | TARSUS PHARMACEUTICALS INC | -- | $77,410.58 | 2,249 | BMH5RL1 |
0.10% | XNCR | XENCOR INC | -- | $76,527.91 | 4,013 | BGCYWN8 |
0.09% | ABCL | ABCELLERA BIOLOGICS INC | -- | $75,362.00 | 19,225 | BL53SR3 |
0.09% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $74,409.55 | 2,099 | BX7RSN3 |
0.09% | PRTA | PROTHENA CORP PLC | -- | $74,088.00 | 3,528 | B91XRN2 |
0.09% | VRNA | VERONA PHARMA PLC - ADR | -- | $73,176.80 | 4,462 | BYWPZK5 |
0.09% | VIR | VIR BIOTECHNOLOGY INC | -- | $73,136.25 | 8,865 | BK4PZ38 |
0.09% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $72,957.15 | 3,059 | BJDX8Y8 |
0.09% | MNKD | MANNKIND CORP | -- | $72,803.70 | 17,757 | BF081J4 |
0.08% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $67,142.78 | 8,686 | BMCWKZ2 |
0.08% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $67,133.64 | 3,206 | BMGS7L1 |
0.08% | MGNX | MACROGENICS INC | -- | $65,607.50 | 4,075 | BFDV8K0 |
0.08% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $65,190.00 | 6,360 | BKX9VD3 |
0.08% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $64,910.60 | 4,738 | BFZQ0L8 |
0.08% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $62,008.62 | 13,539 | 2100362 |
0.08% | INVA | INNOVIVA INC | -- | $60,120.96 | 4,152 | BDDXF67 |
0.07% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $59,254.02 | 4,662 | BMQ5T49 |
0.07% | SPRY | ARS PHARMACEUTICALS INC | -- | $57,123.30 | 6,305 | BMCR7V2 |
0.07% | ETNB | 89BIO INC | -- | $56,068.36 | 6,121 | BK1K484 |
0.07% | OCUL | OCULAR THERAPEUTIX INC | -- | $54,871.62 | 7,239 | BNZB1X8 |
0.07% | RLAY | RELAY THERAPEUTICS INC | -- | $53,492.94 | 8,614 | BN2R582 |
0.07% | GRFS | GRIFOLS SA-ADR | -- | $52,692.64 | 8,008 | B8K7T65 |
0.07% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $52,629.84 | 3,273 | BLN7XQ1 |
0.06% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $51,080.62 | 2,341 | BKDQKM6 |
0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $50,848.44 | 3,954 | BMDWW66 |
0.06% | CGEM | CULLINAN ONCOLOGY INC | -- | $50,224.92 | 2,809 | BM90J52 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $49,967.08 | 6,698 | BP2P6L0 |
0.06% | RGNX | REGENXBIO INC | -- | $49,727.60 | 2,920 | BZ0G875 |
0.06% | SAGE | SAGE THERAPEUTICS INC | -- | $49,651.50 | 3,950 | BP4GNK9 |
0.06% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $48,563.48 | 1,757 | BKC9SX3 |
0.06% | IRON | DISC MEDICINE INC | -- | $47,902.96 | 1,582 | BMGJZJ8 |
0.06% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $46,779.20 | 2,704 | BMFD115 |
0.06% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $46,620.45 | 9,495 | BFWLC09 |
0.06% | NRIX | NURIX THERAPEUTICS INC | -- | $45,196.80 | 3,210 | BMVLGP2 |
0.06% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $44,736.12 | 9,243 | BFMLGR4 |
0.06% | ZLAB | ZAI LAB LTD-ADR | -- | $44,617.44 | 3,252 | BD9GVY0 |
0.06% | COGT | COGENT BIOSCIENCES INC | -- | $44,554.19 | 6,823 | BLR6XK8 |
0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $44,476.80 | 2,624 | BD0MGM0 |
0.06% | SVRA | SAVARA INC | -- | $44,084.48 | 8,888 | BYXGN81 |
0.05% | EOLS | EVOLUS INC | -- | $43,684.92 | 3,753 | BDRJH21 |
0.05% | YMAB | Y-MABS THERAPEUTICS INC | -- | $43,471.47 | 2,877 | BG31GH0 |
0.05% | ORIC | ORIC PHARMACEUTICALS INC | -- | $43,178.24 | 4,424 | BKVDFF7 |
0.05% | CABA | CABALETTA BIO INC | -- | $42,632.10 | 2,814 | BK5MWR1 |
0.05% | ZYME | ZYMEWORKS INC | -- | $40,683.45 | 4,597 | BPCQZY9 |
0.05% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $39,907.56 | 3,702 | BLB0YQ9 |
0.05% | LYEL | LYELL IMMUNOPHARMA INC | -- | $39,710.30 | 16,685 | BN6MB18 |
0.05% | SIGA | SIGA TECHNOLOGIES INC | -- | $39,707.66 | 4,666 | 2107437 |
0.05% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $38,778.48 | 11,048 | BFZNYB7 |
0.05% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $38,748.78 | 3,618 | BMZ4LN0 |
0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $38,377.48 | 8,012 | BYZG9R0 |
0.05% | GLPG | GALAPAGOS NV-SPON ADR | -- | $37,869.12 | 1,296 | B292NQ7 |
0.05% | CVAC | CUREVAC NV | -- | $37,781.57 | 14,701 | BN4RD42 |
0.05% | PRME | PRIME MEDICINE INC | -- | $37,739.15 | 7,655 | BPBJFM7 |
0.05% | ANAB | ANAPTYSBIO INC | -- | $37,486.62 | 1,746 | BDRW1L7 |
0.05% | VERV | VERVE THERAPEUTICS INC | -- | $37,009.34 | 5,491 | BNKGXX2 |
0.05% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $36,857.80 | 3,761 | BJLKVS6 |
0.05% | OABI | OMNIAB INC | -- | $36,485.74 | 7,633 | BN13S71 |
0.04% | NVAX | NOVAVAX INC | -- | $35,749.10 | 9,190 | BJDQXG4 |
0.04% | CSTL | CASTLE BIOSCIENCES INC | -- | $34,006.20 | 1,805 | BKLCWZ3 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $33,475.75 | 2,035 | BYXV9H7 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $32,424.00 | 2,702 | BP9N0G0 |
0.04% | SLRN | ACELYRIN INC | -- | $32,092.86 | 6,393 | BQPF874 |
0.04% | ALEC | ALECTOR INC | -- | $31,875.09 | 6,287 | BJ4LDC4 |
0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $31,816.15 | 2,731 | BD06CS0 |
0.04% | TBPH | THERAVANCE BIOPHARMA INC | -- | $31,149.44 | 3,272 | BMNDK09 |
0.04% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $30,610.58 | 11,011 | BZ0QMB7 |
0.04% | PETQ | PETIQ INC | -- | $30,537.81 | 1,917 | BDH65C8 |
0.04% | EDIT | EDITAS MEDICINE INC | -- | $30,153.75 | 5,375 | BZ8FPH3 |
0.04% | TSHA | TAYSHA GENE THERAPIES INC | -- | $30,081.10 | 12,278 | BNC1BX1 |
0.04% | TVTX | TRAVERE THERAPEUTICS INC | -- | $29,932.03 | 4,997 | BLFGJD5 |
0.04% | THRD | THIRD HARMONIC BIO INC | -- | $29,925.84 | 2,653 | BNNPQY8 |
0.04% | FULC | FULCRUM THERAPEUTICS INC | -- | $29,086.20 | 4,068 | BJDX8Z9 |
0.04% | REPL | REPLIMUNE GROUP INC | -- | $29,077.93 | 4,033 | BDDVW37 |
0.04% | URGN | UROGEN PHARMA LTD | -- | $28,892.96 | 2,029 | BZ7PJQ1 |
0.04% | TRML | TOURMALINE BIO INC | -- | $28,055.76 | 1,682 | BQ80NC6 |
0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $27,593.10 | 3,565 | BY7RB53 |
0.03% | HROW | HARROW INC | -- | $27,233.28 | 2,304 | BHNDW86 |
0.03% | BMEA | BIOMEA FUSION INC | -- | $26,933.00 | 2,342 | BNKF6N0 |
0.03% | MXCT | MAXCYTE INC | -- | $26,807.76 | 6,804 | BKMQF66 |
0.03% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $25,960.50 | 16,025 | BWFZX59 |
0.03% | ITOS | ITEOS THERAPEUTICS INC | -- | $25,076.64 | 2,348 | BMWXFT4 |
0.03% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $24,635.80 | 17,597 | B4N8MH9 |
0.03% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $23,241.00 | 9,525 | BJ5FZ74 |
0.03% | AMRN | AMARIN CORP PLC -ADR | -- | $23,235.65 | 25,336 | 2301938 |
0.03% | CRBU | CARIBOU BIOSCIENCES INC | -- | $22,709.28 | 5,808 | BNYJR68 |
0.03% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $21,941.37 | 5,391 | BYTYP72 |
0.03% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $21,913.50 | 4,174 | BFYQFJ2 |
0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $21,777.92 | 5,792 | BJFSR99 |
0.03% | ATAI | ATAI LIFE SCIENCES NV | -- | $21,587.94 | 10,903 | BN6M8F1 |
0.03% | PGEN | PRECIGEN INC | -- | $21,414.57 | 16,347 | BKM5C84 |
0.03% | HUMA | HUMACYTE INC | -- | $21,228.48 | 6,804 | BMYTJP4 |
0.03% | AVIR | ATEA PHARMACEUTICALS INC | -- | $20,501.46 | 5,526 | BLN9Z50 |
0.03% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $19,962.45 | 8,215 | BNG1NK8 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $19,786.24 | 3,776 | B12W3P6 |
0.02% | TERN | TERNS PHARMACEUTICALS INC | -- | $18,418.78 | 4,057 | BMDJ0C9 |
0.02% | ERAS | ERASCA INC | -- | $18,258.32 | 9,923 | BNLYBF3 |
0.02% | RAPT | RAPT THERAPEUTICS INC | -- | $18,138.24 | 2,256 | BK5T6R0 |
0.02% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $17,181.45 | 1,335 | BL95N25 |
0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $17,046.96 | 3,892 | BMG99Y1 |
0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $16,148.16 | 9,072 | BLR7H87 |
0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $15,720.80 | 7,312 | BRK0149 |
0.02% | ACIU | AC IMMUNE SA | -- | $15,705.80 | 6,490 | BZC0D70 |
0.02% | QURE | UNIQURE NV | -- | $14,682.48 | 3,144 | BJFSR88 |
0.02% | OVID | OVID THERAPEUTICS INC | -- | $14,433.51 | 4,641 | BYPFK63 |
0.02% | EXAI | EXSCIENTIA PLC | -- | $13,685.76 | 3,168 | BP48134 |
0.02% | BLUE | BLUEBIRD BIO INC | -- | $12,042.21 | 12,501 | BBFL7S1 |
0.01% | -- | ACHILLION PHARMACEUTICALS INC - CVR | -- | $11,641.22 | 25,307 | -- |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $8,898.00 | 4,449 | BPCK358 |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $7,378.68 | 20,715 | BM9CKX3 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $5,731.80 | 4,660 | BYV2W40 |
0.01% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $5,162.40 | 3,585 | BM8MVZ3 |
-- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,872.76 | 2,188 | BMHR7T5 |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,757,006.60 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $6,087,506.01 | 6,087,506 | -- |
Index
as of 3/28/2024
- Total Number of Companies218
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$6.77 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|